SCHEMBL8447306

SCHEMBL8447306

CC(=NOCCOc1ccc(CC2SC(=O)N(C(c3ccccc3)(c3ccccc3)c3ccccc3)C2=O)cc1)c1ccc(-c2ccccn2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 9/20 0.56
RARG P13631 1/20 0.36
RXRA P19793 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP19A1 P11511 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
ESR1 P03372 1/20 0.35
MAPT P10636 1/20 0.34
S1PR1 P21453 1/20 0.34
HTT P42858 1/20 0.33
FFAR1 O14842 3/20 0.33
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ABL1 P00519 1/20 0.31
BCR P11274 1/20 0.31
PPARA Q07869 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8307062 0.91 PPARG (0.55) PPARGMAPTS1PR1HTTFFAR1
SCHEMBL8307060 0.91 PPARG (0.55) PPARGMAPTS1PR1HTTFFAR1
SCHEMBL8444587 0.91 PPARG (0.51) PPARGRARGRXRAMAPTS1PR1
SCHEMBL8305173 0.90 PPARG (0.69) PPARGRARGRXRAMAPTS1PR1
SCHEMBL8305170 0.90 PPARG (0.69) PPARGRARGRXRAMAPTS1PR1
SCHEMBL8309781 0.89 PPARG (0.51) PPARGMAPTS1PR1HTTFFAR1
SCHEMBL8309782 0.89 PPARG (0.51) PPARGMAPTS1PR1HTTFFAR1
SCHEMBL8309618 0.88 PPARG (0.50) PPARGMAPTS1PR1HTTFFAR1
SCHEMBL8309616 0.88 PPARG (0.50) PPARGMAPTS1PR1HTTFFAR1
SCHEMBL8305087 0.88 PPARG (0.51) PPARGESR1MAPTS1PR1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed